Dose-escalation study to evaluate ORB-011 as single agent, with initial safety, pharmacokinetic and mechanism-based pharmacodynamic readouts
Orionis Biosciences, a life sciences company pioneering the creation...
Charles River Laboratories International, Inc. and Aitia, a leader in the application of Causal AI and Digital Twins, announced a strategic agreement that gives Aitia...
Code Ocean, the world's first Reproducible Research Cloud, announced that it has been selected as a winner of the 2023 BioTech Breakthrough Awards in the...
VeriSIM Life announces recognition for continued advances with BIOiSIM, a first-in-class virtual drug development engine.
VeriSIM Life— the leading artificial intelligence (AI)-enabled, unique R&D decisions...
A global consortium of scientists from federal laboratories, research institutes, academia, and industry has formed to address the challenges of building large-scale artificial intelligence (AI) systems...
Bayer and US-based Recursion Pharmaceuticals, Inc., a clinical stage TechBio company decoding biology to industrialize drug discovery, announced that they have updated the focus...
Certis Oncology Solutions (Certis), a translational science and precision oncology company, announced it has been selected as "Overall Immunology Company of the Year" in...
Investment supported by additional financing from a strong syndicate of new and existing institutional investors, along with industry leaders
Terray Therapeutics, a biotechnology company integrating...
Osmo, a machine olfaction startup, announced the receipt of a $3.5 million grant from the Bill & Melinda Gates Foundation to advance the company's AI-enabled scent...
Alimentiv Inc., AcelaBio Inc. and PharmaNest Inc. announce a collaboration to provide precision medicine and artificial intelligence (AI)-powered digital pathology solutions for metabolic dysfunction-associated...